SGLT‐2is have been shown to decrease hyperglycaemia to a similar extent in both T1DM and T2DM, improve insulin sensitivity in T2DM,111 promote weight loss and decrease tissue inflammation and subsequent effects on the kidneys. The gene discussed is INS; the disease is type 1 diabetes mellitus.